Literature DB >> 21708121

Human diseases with impaired mitochondrial protein synthesis.

Agnès Rötig1.   

Abstract

Mitochondrial respiratory chain deficiencies represent one of the major causes of metabolic disorders that are related to genetic defects in mitochondrial or nuclear DNA. The mitochondrial protein synthesis allows the synthesis of the 13 respiratory chain subunits encoded by mtDNA. Altogether, about 100 different proteins are involved in the translation of the 13 proteins encoded by the mitochondrial genome emphasizing the considerable investment required to maintain mitochondrial genetic system. Mitochondrial protein synthesis deficiency can be caused by mutations in any component of the translation apparatus including tRNA, rRNA and proteins. Mutations in mitochondrial rRNA and tRNAs have been first identified in various forms of mitochondrial disorders. Moreover abnormal translation due to mutation in nuclear genes encoding tRNA-modifying enzymes, ribosomal proteins, aminoacyl-tRNA synthetases, elongation and termination factors and translational activators have been successively described. These deficiencies are characterized by a huge clinical and genetic heterogeneity hampering to establish genotype-phenotype correlations and an easy diagnosis. One can hypothesize that a new technique for gene identification, such as exome sequencing will rapidly allow to expand the list of genes involved in abnormal mitochondrial protein synthesis. 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21708121     DOI: 10.1016/j.bbabio.2011.06.010

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  65 in total

1.  Biochemical Evidence for a Nuclear Modifier Allele (A10S) in TRMU (Methylaminomethyl-2-thiouridylate-methyltransferase) Related to Mitochondrial tRNA Modification in the Phenotypic Manifestation of Deafness-associated 12S rRNA Mutation.

Authors:  Feilong Meng; Xiaohui Cang; Yanyan Peng; Ronghua Li; Zhengyue Zhang; Fushan Li; Qingqing Fan; Anna S Guan; Nathan Fischel-Ghosian; Xiaoli Zhao; Min-Xin Guan
Journal:  J Biol Chem       Date:  2017-01-03       Impact factor: 5.157

Review 2.  Mitochondrial ribosome assembly in health and disease.

Authors:  Dasmanthie De Silva; Ya-Ting Tu; Alexey Amunts; Flavia Fontanesi; Antoni Barrientos
Journal:  Cell Cycle       Date:  2015-06-01       Impact factor: 4.534

Review 3.  Challenges of bringing next generation sequencing technologies to clinical molecular diagnostic laboratories.

Authors:  Lee-Jun C Wong
Journal:  Neurotherapeutics       Date:  2013-04       Impact factor: 7.620

4.  Cryo-EM structure of the small subunit of the mammalian mitochondrial ribosome.

Authors:  Prem S Kaushal; Manjuli R Sharma; Timothy M Booth; Emdadul M Haque; Chang-Shung Tung; Karissa Y Sanbonmatsu; Linda L Spremulli; Rajendra K Agrawal
Journal:  Proc Natl Acad Sci U S A       Date:  2014-05-05       Impact factor: 11.205

5.  Activation of a cryptic splice site in the mitochondrial elongation factor GFM1 causes combined OXPHOS deficiency.

Authors:  Mariella T Simon; Bobby G Ng; Marisa W Friederich; Raymond Y Wang; Monica Boyer; Martin Kircher; Renata Collard; Kati J Buckingham; Richard Chang; Jay Shendure; Deborah A Nickerson; Michael J Bamshad; Johan L K Van Hove; Hudson H Freeze; Jose E Abdenur
Journal:  Mitochondrion       Date:  2017-02-12       Impact factor: 4.160

6.  Yeast Mitoribosome Large Subunit Assembly Proceeds by Hierarchical Incorporation of Protein Clusters and Modules on the Inner Membrane.

Authors:  Rui Zeng; Erin Smith; Antoni Barrientos
Journal:  Cell Metab       Date:  2018-03-06       Impact factor: 27.287

Review 7.  When a common biological role does not imply common disease outcomes: Disparate pathology linked to human mitochondrial aminoacyl-tRNA synthetases.

Authors:  Ligia Elena González-Serrano; Joseph W Chihade; Marie Sissler
Journal:  J Biol Chem       Date:  2019-01-15       Impact factor: 5.157

Review 8.  Protecting the mitochondrial powerhouse.

Authors:  Morten Scheibye-Knudsen; Evandro F Fang; Deborah L Croteau; David M Wilson; Vilhelm A Bohr
Journal:  Trends Cell Biol       Date:  2014-12-11       Impact factor: 20.808

9.  A de novo POU3F3 Deletion in a Boy with Intellectual Disability and Dysmorphic Features.

Authors:  A Dheedene; M Maes; S Vergult; B Menten
Journal:  Mol Syndromol       Date:  2013-11-02

10.  AFG3L2 supports mitochondrial protein synthesis and Purkinje cell survival.

Authors:  Eva R Almajan; Ricarda Richter; Lars Paeger; Paola Martinelli; Esther Barth; Thorsten Decker; Nils-Göran Larsson; Peter Kloppenburg; Thomas Langer; Elena I Rugarli
Journal:  J Clin Invest       Date:  2012-10-08       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.